Elusive And Expensive: COVID-19 Life Saving Drugs

Covid-19 life-saving drugs Tocilizumab and Remdesivir are not easily available for relatives of patients who might need them.

How is a shortage of life-saving drugs against COVID-19 like Tocilizumab and Remdesivir pushing families of coronavirus patients to desperation? Relatives of COVID-19 positive patients say they are charged between Rs 31,500 - 72,000 to source a 400 mg vial of Tocilizumab on the black market.


If you value our work, we have an ask:

Our journalists work with TruthSeekers like you to publish fact-checks, explainers, ground reports and media literacy content. Much of this work involves using investigative methods and forensic tools. Our work is resource-intensive, and we rely on our readers to fund our work. Support us so we can continue our work of decluttering the information landscape.

BECOME A MEMBER
📧 Subscribe to our newsletter here.

📣You can also follow us on Twitter, Facebook, Instagram, Youtube, Linkedin and Google News
Show Full Article
Next Story
Our website is made possible by displaying online advertisements to our visitors.
Please consider supporting us by disabling your ad blocker. Please reload after ad blocker is disabled.

Hey, Check these before you go!

×